 Vasodilator Agents
"Vasodilator Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used to cause dilation of the blood vessels.
| Descriptor ID |
D014665
|
| MeSH Number(s) |
D27.505.954.411.918
|
| Concept/Terms |
Vasodilator Agents- Vasodilator Agents
- Agents, Vasodilator
- Vasodilators
- Vasorelaxants
- Vasodilator Drugs
- Drugs, Vasodilator
|
Below are MeSH descriptors whose meaning is more general than "Vasodilator Agents".
Below are MeSH descriptors whose meaning is more specific than "Vasodilator Agents".
This graph shows the total number of publications written about "Vasodilator Agents" by people in UAMS Profiles by year, and whether "Vasodilator Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2023 | 0 | 1 | 1 | | 2022 | 0 | 2 | 2 | | 2021 | 0 | 3 | 3 | | 2019 | 2 | 0 | 2 | | 2018 | 0 | 2 | 2 | | 2017 | 4 | 1 | 5 | | 2016 | 3 | 3 | 6 | | 2015 | 4 | 1 | 5 | | 2014 | 2 | 0 | 2 | | 2013 | 0 | 2 | 2 | | 2012 | 1 | 2 | 3 | | 2011 | 1 | 3 | 4 | | 2010 | 0 | 2 | 2 | | 2009 | 1 | 1 | 2 | | 2008 | 3 | 1 | 4 | | 2007 | 1 | 4 | 5 | | 2006 | 0 | 2 | 2 | | 2005 | 0 | 3 | 3 | | 2004 | 1 | 2 | 3 | | 2003 | 1 | 0 | 1 | | 2000 | 1 | 0 | 1 | | 1999 | 1 | 0 | 1 | | 1997 | 1 | 0 | 1 | | 1996 | 1 | 1 | 2 | | 1995 | 0 | 1 | 1 | | 1993 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Vasodilator Agents" by people in Profiles over the past ten years.
-
Shah VA, Gonzalez LF, Suarez JI. Therapies for Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage. Neurocrit Care. 2023 08; 39(1):36-50.
-
Mansour M, Alqaisi O, Malkawi A, Alaiwah M, Radaideh Q, Al'Aref SJ, Fudim M, Douglas P, Vallurupalli S. Significance of indeterminate and abnormal stress electrocardiography despite normal imaging in patients with suspected coronary artery disease - An analysis of the PROMISE trial. J Electrocardiol. 2022 Jul-Aug; 73:79-86.
-
Sharma M, Callan E, Konduri GG. Pulmonary Vasodilator Therapy in Persistent Pulmonary Hypertension of the Newborn. Clin Perinatol. 2022 03; 49(1):103-125.
-
Maddux AB, Mourani PM, Banks R, Reeder RW, Pollack MM, Berg RA, Meert KL, McQuillen PS, Yates AR, Notterman DA, Berger JT. Inhaled Nitric Oxide Use and Outcomes in Critically Ill Children With a History of Prematurity. Respir Care. 2021 Oct; 66(10):1549-1559.
-
Coleman RD, Chartan CA, Mourani PM. Intensive care management of right ventricular failure and pulmonary hypertension crises. Pediatr Pulmonol. 2021 03; 56(3):636-648.
-
Vaiyani D, Matsuo K, Kanaan U, Patel B, Akintoye O, Travers CD, Kelleman M, Sachdeva R, Petit CJ. Total vascular resistance increases during volume-unloading in asymptomatic single ventricle patients. Am Heart J. 2021 06; 236:69-79.
-
Mao G, Gigliotti MJ, Esplin N, Sexton K. The clinical impact and safety profile of high-dose intra-arterial verapamil treatment for cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Clin Neurol Neurosurg. 2021 Mar; 202:106546.
-
Fares M, Critser PJ, Arruda MJ, Wilhelm CM, Rattan MS, Lang SM, Alsaied T. Pharmacologic stress cardiovascular magnetic resonance in the pediatric population: A review of the literature, proposed protocol, and two examples in patients with Kawasaki disease. Congenit Heart Dis. 2019 Nov; 14(6):1166-1175.
-
Hornik CP, Yogev R, Mourani PM, Watt KM, Sullivan JE, Atz AM, Speicher D, Al-Uzri A, Adu-Darko M, Payne EH, Gelber CE, Lin S, Harper B, Melloni C, Cohen-Wolkowiez M, Gonzalez D. Population Pharmacokinetics of Milrinone in Infants, Children, and Adolescents. J Clin Pharmacol. 2019 12; 59(12):1606-1619.
-
Miller BS, Blumenthal SR, Shalygin A, Wright KD, Staruschenko A, Imig JD, Sorokin A. Inactivation of p66Shc Decreases Afferent Arteriolar KATP Channel Activity and Decreases Renal Damage in Diabetic Dahl SS Rats. Diabetes. 2018 11; 67(11):2206-2212.
-
Sbeih F, Christov F, Gluth MB. Newly Diagnosed Meniere's Disease: Clinical Course With Initiation of Noninvasive Treatment Including an Accounting of Vestibular Migraine. Ann Otol Rhinol Laryngol. 2018 May; 127(5):331-337.
-
Dasgupta S, Qasim A, Aly AM, Jain SK. Mother With Diabetes Mellitus and Infant With Hypertrophic Obstructive Cardiomyopathy: Milrinone Precluded Need for Extracorporeal Membrane Oxygenation. Circ Cardiovasc Imaging. 2017 11; 10(11).
-
Armstrong BA, Betzold RD, May AK. Sepsis and Septic Shock Strategies. Surg Clin North Am. 2017 Dec; 97(6):1339-1379.
-
Manicam C, Ginter N, Li H, Xia N, Goloborodko E, Zadeh JK, Musayeva A, Pfeiffer N, Gericke A. Compensatory Vasodilator Mechanisms in the Ophthalmic Artery of Endothelial Nitric Oxide Synthase Gene Knockout Mice. Sci Rep. 2017 08 02; 7(1):7111.
-
Phillips JD, Zhang H, Wei T, Richter GT. Expression of ?-Adrenergic Receptor Subtypes in Proliferative, Involuted, and Propranolol-Responsive Infantile Hemangiomas. JAMA Facial Plast Surg. 2017 Mar 01; 19(2):102-107.
-
Abdelaziz HK, Elkilany W, Khalid S, Sabet S, Saad M. Efficacy and safety of intracoronary verapamil versus sodium nitroprusside for the prevention of microvascular obstruction during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Coron Artery Dis. 2017 Jan; 28(1):11-16.
-
Tadphale SD, Rettiganti M, Gossett JM, Beam BW, Padiyath A, Schmitz ML, Gupta P. Is Administration of Nitric Oxide During Extracorporeal Membrane Oxygenation Associated With Improved Patient Survival? Pediatr Crit Care Med. 2016 11; 17(11):1080-1087.
-
Agarwal SK, Kasula S, Almomani A, Hacioglu Y, Ahmed Z, Uretsky BF, Hakeem A. Clinical and angiographic predictors of persistently ischemic fractional flow reserve after percutaneous revascularization. Am Heart J. 2017 02; 184:10-16.
-
Hammond DA, Smith MN, Lee KC, Honein D, Quidley AM. Acute Decompensated Heart Failure. J Intensive Care Med. 2018 Aug; 33(8):456-466.
-
Sporkov? A, Reddy RN, Falck JR, Imig JD, Kopkan L, Sadowski J, Cervenka L. Interlobular Arteries From 2-Kidney, 1-Clip Goldblatt Hypertensive Rats' Exhibit-Impaired Vasodilator Response to Epoxyeicosatrienoic Acids. Am J Med Sci. 2016 05; 351(5):513-9.
-
Moon RE, Martina SD, Peacher DF, Potter JF, Wester TE, Cherry AD, Natoli MJ, Otteni CE, Kernagis DN, White WD, Freiberger JJ. Swimming-Induced Pulmonary Edema: Pathophysiology and Risk Reduction With Sildenafil. Circulation. 2016 Mar 08; 133(10):988-96.
-
Elraiyah T, Tsapas A, Prutsky G, Domecq JP, Hasan R, Firwana B, Nabhan M, Prokop L, Hingorani A, Claus PL, Steinkraus LW, Murad MH. A systematic review and meta-analysis of adjunctive therapies in diabetic foot ulcers. J Vasc Surg. 2016 Feb; 63(2 Suppl):46S-58S.e1-2.
-
Hye Khan MA, Sharma A, Rarick KR, Roman RJ, Harder DR, Imig JD. Elevated Aminopeptidase P Attenuates Cerebral Arterial Responses to Bradykinin in Fawn-Hooded Hypertensive Rats. PLoS One. 2015; 10(12):e0145335.
-
Hakeem A, Garg A, Bhatti S, Ahmed Z, Uretsky BF. Fractional flow reserve in acute coronary syndrome: a word of caution. EuroIntervention. 2015 Dec; 11(8):e1-2.
-
Elluru RG, Friess MR, Richter GT, Grimmer JF, Darrow DH, Shin JJ, Perkins JA. Multicenter Evaluation of the Effectiveness of Systemic Propranolol in the Treatment of Airway Hemangiomas. Otolaryngol Head Neck Surg. 2015 Sep; 153(3):452-60.
-
Flores S, Daily J, Pratap JN, Cash MC, Hirsch R. Management of a child with pulmonary arterial hypertension presenting with systemic hypertension. Cardiol Young. 2016 Feb; 26(2):378-81.
-
Hakeem A, Uretsky BF. "Just do it!" redux. Catheter Cardiovasc Interv. 2015 May; 85(6):977-8.
-
Tas E, Mahmood B, Garibaldi L, Sperling M. Liver injury may increase the risk of diazoxide toxicity: a case report. Eur J Pediatr. 2015 Mar; 174(3):403-6.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|